New state-of-the-art facility in Plainville, Mass., to manufacture materials central to production of gene-based therapeutics PLAINVILLE, Mass. — Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previously announced viral vector manufacturing facility in Plainville, Mass. The 300,000 square foot, state-of-the-art site will […]
JAKARTA, Indonesia — MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, today announced that the National Genome Project in Indonesia has selected MGI technology* as one of the technology providers for the first phase of its effort towards establishing an accountable, accurate, and credible population database of 10,000 whole genomes. Genomics science has been […]
The Digital LightCycler System is a next-generation digital PCR system that helps clinical researchers better understand the nature of a patient’s cancer, genetic disease or infection. The new system has the potential to find and quantify ultra-rare, hard to detect mutations, leading to early diagnosis and treatment strategies. The Digital LightCycler System is designed for laboratories performing highly sensitive and precise DNA and RNA […]
The Digital LightCycler System is a next-generation digital PCR system that helps clinical researchers better understand the nature of a patient’s cancer, genetic disease or infection. The new system has the potential to find and quantify ultra-rare, hard to detect mutations, leading to early diagnosis and treatment strategies. The Digital LightCycler System is designed for laboratories performing highly sensitive and precise DNA and RNA […]
Session will focus on disrupting the status quo by empowering consumers to make more proactive, informed health care decisions SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature Anne Wojcicki, co-founder and CEO of personal genomics company 23andMe, at its inaugural Illumina Genomics […]
LANSING, Mich. — Neogen Corporation (“Neogen”) (NASDAQ: NEOG) announced that, at the special meeting of Neogen shareholders held today, Neogen shareholders voted to approve all proposals required in connection with the pending combination of the food safety business of 3M Company (“3M”) (NYSE: MMM) with Neogen, including the issuance of shares of Neogen common stock pursuant […]
LGC’s latest environmental, social and governance (ESG) report is now available, covering the period of 1 April 2021 – 31 March 2022. This is LGC’s second ESG report using the Global Reporting Initiative (GRI) Standards, the most widely used sustainability reporting framework globally. Euan O’Sullivan, LGC’s President and Chief Executive Officer, explained, “Last year, I shared […]
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled […]
New partnership will use the power of high-throughput sequencing to measure and understand marine life in our oceans at a rate that eclipses traditional research methods SAN DIEGO — Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific […]
Session will showcase the rapidly growing use and groundbreaking impact of clinical genomics in oncology SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature Dr. Karen Knudsen, CEO of the American Cancer Society, at its inaugural Illumina Genomics Forum (IGF) on October 1. […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
